289 related articles for article (PubMed ID: 21380984)
1. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.
Rafael TJ; Mackeen AD; Berghella V
Am J Perinatol; 2011 May; 28(5):389-94. PubMed ID: 21380984
[TBL] [Abstract][Full Text] [Related]
2. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.
Berghella V; Figueroa D; Szychowski JM; Owen J; Hankins GD; Iams JD; Sheffield JS; Perez-Delboy A; Wing DA; Guzman ER;
Am J Obstet Gynecol; 2010 Apr; 202(4):351.e1-6. PubMed ID: 20350641
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of 17-α-hydroxyprogesterone caproate on preterm birth prevention in women with history-indicated cerclage.
Mackeen AD; Rafael TJ; Zavodnick J; Berghella V
Am J Perinatol; 2013 Oct; 30(9):755-8. PubMed ID: 23341330
[TBL] [Abstract][Full Text] [Related]
4. Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate.
Szychowski JM; Berghella V; Owen J; Hankins G; Iams JD; Sheffield JS; Perez-Delboy A; Wing DA; Guzman ER;
J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2686-9. PubMed ID: 22889234
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Intramuscular 17α-Hydroxyprogesterone in Women Screened for Shortened Cervical Length.
Wood SL; Williams BN; Szychowski JM; Owen J
Am J Perinatol; 2020 Jun; 37(7):659-665. PubMed ID: 31756763
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix.
Keeler SM; Kiefer D; Rochon M; Quinones JN; Novetsky AP; Rust O
J Perinat Med; 2009; 37(5):473-9. PubMed ID: 19492920
[TBL] [Abstract][Full Text] [Related]
7. Role of Cervical Cerclage and Vaginal Progesterone in the Treatment of Cervical Incompetence with/without Preterm Birth History.
Wang SW; Ma LL; Huang S; Liang L; Zhang JR
Chin Med J (Engl); 2016 Nov; 129(22):2670-2675. PubMed ID: 27823998
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 2 stitches vs 1 stitch for transvaginal cervical cerclage for preterm birth prevention.
Giraldo-Isaza MA; Fried GP; Hegarty SE; Suescum-Diaz MA; Cohen AW; Berghella V
Am J Obstet Gynecol; 2013 Mar; 208(3):209.e1-9. PubMed ID: 23201330
[TBL] [Abstract][Full Text] [Related]
9. Cerclage, progesterone and α-hydroxyprogeterone caproate treatment in women at risk for preterm delivery.
Haram K; Mortensen JH; Morrison JC
J Matern Fetal Neonatal Med; 2014 Nov; 27(16):1710-5. PubMed ID: 24678618
[TBL] [Abstract][Full Text] [Related]
10. Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial.
Senat MV; Porcher R; Winer N; Vayssière C; Deruelle P; Capelle M; Bretelle F; Perrotin F; Laurent Y; Connan L; Langer B; Mantel A; Azimi S; Rozenberg P;
Am J Obstet Gynecol; 2013 Mar; 208(3):194.e1-8. PubMed ID: 23433324
[TBL] [Abstract][Full Text] [Related]
11. Can the optimal cervical length for placing ultrasound-indicated cerclage be identified?
Szychowski JM; Owen J; Hankins G; Iams JD; Sheffield JS; Perez-Delboy A; Berghella V; Wing DA; Guzman ER;
Ultrasound Obstet Gynecol; 2016 Jul; 48(1):43-7. PubMed ID: 26277877
[TBL] [Abstract][Full Text] [Related]
12. Cervical cerclage: one stitch or two?
Park JM; Tuuli MG; Wong M; Carbone JF; Ismail M; Macones GA; Odibo AO
Am J Perinatol; 2012 Jun; 29(6):477-81. PubMed ID: 22399222
[TBL] [Abstract][Full Text] [Related]
13. Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery.
González-Quintero VH; Istwan NB; Rhea DJ; Smarkusky L; Hoffman MC; Stanziano GJ
J Matern Fetal Neonatal Med; 2007 Mar; 20(3):249-52. PubMed ID: 17437227
[TBL] [Abstract][Full Text] [Related]
14. Recurrent preterm birth in women treated with 17 α-hydroxyprogesterone caproate: the contribution of risk factors in the penultimate pregnancy.
Coleman S; Wallace L; Alexander J; Istwan N
J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1034-8. PubMed ID: 21854134
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous preterm birth in African-American and Caucasian women receiving 17α-hydroxyprogesterone caproate.
Timofeev J; Singh J; Istwan N; Rhea D; Driggers RW
Am J Perinatol; 2014 Jan; 31(1):55-60. PubMed ID: 23456908
[TBL] [Abstract][Full Text] [Related]
16. Indomethacin administration at the time of ultrasound-indicated cerclage: is there an association with a reduction in spontaneous preterm birth?
Visintine J; Airoldi J; Berghella V
Am J Obstet Gynecol; 2008 Jun; 198(6):643.e1-3. PubMed ID: 18221923
[TBL] [Abstract][Full Text] [Related]
17. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
Winer N; Bretelle F; Senat MV; Bohec C; Deruelle P; Perrotin F; Connan L; Vayssière C; Langer B; Capelle M; Azimi S; Porcher R; Rozenberg P;
Am J Obstet Gynecol; 2015 Apr; 212(4):485.e1-485.e10. PubMed ID: 25448515
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after periviable ultrasound-indicated cerclage.
Drassinower D; Coviello E; Landy HJ; Gyamfi-Bannerman C; Perez-Delboy A; Friedman AM
J Matern Fetal Neonatal Med; 2019 Mar; 32(6):932-938. PubMed ID: 29108444
[TBL] [Abstract][Full Text] [Related]
19. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
[TBL] [Abstract][Full Text] [Related]
20. Does adjunctive use of progesterone in women with cerclage improve prevention of preterm birth?
Sinkey RG; Garcia MR; Odibo AO
J Matern Fetal Neonatal Med; 2018 Jan; 31(2):202-208. PubMed ID: 28068860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]